January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Julie Bullock, PharmD
Advertisement
Articles by Julie Bullock, PharmD
Applied Clinical Trials
How the use of M&S in cancer trials from the outset can help address those critical “what if?” scenarios and accelerate oncology drug development.
Advertisement
Latest Updated Articles
Leveraging Modeling & Simulation in OncologySeptember 1st 2018
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent
2
ACT Brief: APAC Inspection Findings, RBQM Key Risk Indicators, and Head and Neck Cancer Approval
3
How China Cut Its Phase III Startup Timeline and What Drove the Change
4
What FDA Inspections Reveal About the Quality of APAC Clinical Trial Sites
5